“`html
Severe RSV Infections in Infancy Linked to Higher Asthma Risk, Study Finds
Table of Contents
Protecting newborns from severe respiratory syncytial virus (RSV) infections could significantly reduce the incidence of childhood asthma, particularly in families with a history of allergies, according to groundbreaking new research. The study, published in the journal Science Immunology, highlights a critical window of immune system vulnerability in early life.
New research reveals a concerning connection between early childhood illness adn long-term respiratory health. Scientists now believe that a combination of RSV infection during infancy and pre-existing genetic allergy risks creates a heightened susceptibility to developing asthma, a chronic inflammatory disease of the airways.
“This study underscores how the immune system is uniquely vulnerable in the very first weeks of life,” stated a lead researcher from the VIB-UGent Center for Inflammation Research (IRC). “A single viral insult during this window can shape respiratory health for years.”
The RSV-Asthma Connection: A Growing Concern
While RSV typically presents as a mild, cold-like illness, it can be dangerous for infants under six months old. The virus is a notable burden on healthcare systems, leading to approximately 213,000 hospitalizations annually for children under five across the European Union, Norway, and the United Kingdom. Currently, 5.7% of EU residents have been diagnosed with asthma, with rates varying considerably across the continent – from 1.5% in Romania to 9.4% in finland.
Researchers analyzed thorough health data from all children born in Denmark between 1994 and 2018, supplementing this with controlled laboratory experiments. Their findings revealed that newborns hospitalized due to RSV infections were three times more likely to receive an asthma diagnosis compared to those who were not hospitalized. This risk was even more pronounced for babies with parents who also had asthma.
Previous studies have suggested a link between RSV and childhood asthma, but establishing a direct causal relationship has proven challenging. This new research provides stronger evidence of that connection.
Immune changes and Maternal antibodies
In laboratory experiments using mice, researchers discovered that viral infections trigger immune system changes, increasing newborns’ vulnerability to common allergens like house dust mites. Furthermore, they found that mothers with allergies pass on related antibodies to their babies, perhaps amplifying their sensitivity to these irritants.
This suggests a complex interplay between genetic predisposition, early viral exposure, and the maternal immune system in shaping a child’s respiratory health.
The Promise of RSV Vaccination
The study’s findings underscore the importance of preventing RSV infection,particularly in vulnerable infants. “If preventing RSV infection also reduces asthma risk, the benefits for families and health systems could be enormous,” explained a senior researcher and IRC’s science director.
The European Union approved the first RSV vaccine to protect babies up to six months old in 2023. the vaccine is administered to pregnant women, generating antibodies that are then passed on to the developing fetus, providing early protection. Currently, health authorities recommend the vaccine for pregnant women in Belgium, France, Luxembourg, and Slovenia, tho vaccine uptake remains inconsistent.
“This is a moment where policy,science,and paediatricians can come together,” the researcher ad
